Zhejiang Wolwo Biopharmaceutical Co., Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Zhejiang Wolwo Biopharmaceutical Co., Ltd - overview
Established
2002
Location
Zhuzhou, Zhejiang, China
Primary Industry
Pharmaceuticals
About
Founded in 2002 and based in Huzhou, China, Zhejiang Wolwo Biopharmaceutical Co. , Ltd operates as a biopharmaceutical company that focuses on the research and development of desensitization treatment drugs and diagnostic reagents. It was recognized as the National High-tech Enterprise. In December 2010, the company closed a venture funding.
The company has a branch office in Shanghai. In January 2014, Zhejiang Wolwo Biopharmaceutical Co. , Ltd was listed on the Shenzhen Stock Exchange. Its products were officially sold in South Korea, entering the international market in 2016.
The company's main business is the research and development of biopharmaceuticals and innovative drugs. Products include stem cell drugs, traditional Chinese medicine, products with quasi-medical functions, medical devices and other categories. The main products include desensitization treatment drugs and diagnostic reagents, Silk Armor Silk Protein Moisturizing Cream, Pollen Allergen Skin Prick Solution, etc. The company generates revenue by providing desensitization treatment drugs and diagnostic reagents.
Current Investors
Oriental Fortune Capital, Lehel Capital
Primary Industry
Pharmaceuticals
Sub Industries
Consumer Products, Drug Stores/Convenience Stores, Diagnostic Equipment, Medical Equipment Distributors, Pharmaceuticals
Website
www.wolwobiotech.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.